Changes to Medicare Part D May Affect the Creditable Coverage Status of Employer Plans
The Inflation Reduction Act of 2022 (IRA) includes several cost-reduction provisions affecting Medicare Part D plans, which may impact the creditable coverage status of employer-sponsored prescription drug coverage beginning in 2025.
Employer Action Items
- Employers should monitor CMS’ final program instructions for 2025, which are expected to be published no later than April 1, 2024.
- Employers should confirm whether the prescription drug coverage offered under their group health plans for 2025 is creditable or non-creditable as soon as possible, as the deadlines for preparation and submission of the Medicare Part D disclosure notices is approaching.
Under existing CMS guidance, there are a few different ways for an employer to determine whether its prescription drug coverage is creditable:
- As a first step, employers with insured prescription drug plans should ask their carriers whether they have determined whether the plan’s coverage is creditable.
- For self-insured plans, or where the carrier for an insured plan has not yet decided whether the plan is creditable, employers may use a simplified determination if the coverage meets certain design requirements. If it doesn’t, the employer must use an actuarial determination method. However, CMS has stated that the simplified determination method will no longer be a valid methodology to determine creditable coverage status as of calendar year 2025.
According to the CMS, as of calendar year 2025, the simplified determination methodology will no longer be valid to determine whether an entity’s prescription drug coverage is creditable.
Summary
Employers that provide prescription drug coverage to individuals who are eligible for Medicare Part D must inform these individuals and the Centers for Medicare & Medicaid Services (CMS) whether their prescription drug coverage is creditable, meaning that the employer’s prescription drug coverage is at least as good as Medicare Part D coverage.
CMS’ Draft Part D Redesign Program Instructions state that given the significant changes that the IRA made to Medicare Part D, one of the methods for determining whether employer-sponsored prescription drug coverage is creditable will no longer be valid as of calendar year 2025. These draft program instructions are subject to change, and CMS will issue final program instructions for 2025 after considering the public comments received in response to the draft program instructions.
Disclosure to Individuals
Plan sponsors must provide creditable coverage disclosure notices to individuals each year before October 15—the beginning date for the Medicare Part D annual enrollment period. The disclosure notice alerts individuals as to whether the employer’s group health plan prescription drug coverage is deemed creditable. Model notices are available for employers to use.
Disclosure to Individuals
The disclosure to CMS is due within 60 days after the start of each plan year. For calendar year plans, this deadline is March 1 of each year (Feb. 29 for leap years). Plan sponsors are required to use the online disclosure form prepared by CMS.
Enforcement
There is no penalty or fee to the employer to the extent any prescription coverage offered that is non-creditable in nature. Non-creditable prescription drug coverage can still be a valuable benefit for employees. However, individuals need to know whether their prescription drug coverage is creditable or non-creditable. If the coverage is non-creditable and Medicare-eligible individuals fail to enroll in Part D during their initial enrollment period, they may be subject to a higher Part D premium if they enroll in Part D at a later date.
Additional Information on Medicare
More information and resources related to the IRA’s changes to the Medicare Part D program are available on the CMS Part D Improvements webpage.
For more information
We’re ready when you are. Get in touch and a friendly, knowledgeable Baldwin advisor is prepared to discuss your business or individual needs, ask a few questions to get the full picture, and make a plan to follow up.
This document is intended for general information purposes only and should not be construed as advice or opinions on any specific facts or circumstances. The content of this document is made available on an “as is” basis, without warranty of any kind. The Baldwin Insurance Group Holdings, LLC (“The Baldwin Group”), its affiliates, and subsidiaries do not guarantee that this information is, or can be relied on for, compliance with any law or regulation, assurance against preventable losses, or freedom from legal liability. This publication is not intended to be legal, underwriting, or any other type of professional advice. The Baldwin Group does not guarantee any particular outcome and makes no commitment to update any information herein or remove any items that are no longer accurate or complete. Furthermore, The Baldwin Group does not assume any liability to any person or organization for loss or damage caused by or resulting from any reliance placed on that content. Persons requiring advice should always consult an independent adviser.
The Baldwin Group offers insurance services through one or more of its insurance licensed entities. Each of the entities may be known by one or more of the logos displayed; all insurance commerce is only conducted through The Baldwin Group insurance licensed entities. This material is not an offer to sell insurance.
